Novartis India Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Novartis India Ltd. from all sources in a single place.

Load latest

Novartis India Ltd.

21 Nov 2024

886.15

0.37%

Corp. Note

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

The intimation is filed under Reg 39(3) of SEBI LODR as per the information received from the company`s RTA for the loss of share certificate by the shareholder as on November 20, 2024.

pdf

Novartis India Ltd.

21 Nov 2024

886.15

0.37%

Novartis Raises Sales Guidance Citing Cancer, Inflammatory Drugs

NDTV Profit

The company lifted its peak sales estimates for its Cosentyx, Kisqali, Kesimpta, Pluvicto and Leqvio drugs, most of which have expected US exclusivity in the 2030s or beyond.

Novartis India Ltd. is trading below all available SMAs

Novartis India Ltd.

20 Nov 2024

886.15

0.37%

Corp. Note

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Filing of Intimation under Reg 39(3) of SEBI LODR 2015 received from RTA of the Company providing the information regarding the issue of Duplicate Share Certificate to shareholders as of November 19, 2024. The letter received from RTA is also enclosed with this intimation.

pdf

Novartis India Ltd.

15 Nov 2024

886.15

0.37%

Corp. Note

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Filing of Intimation r/r 39(3) received from Company''s RTA for loss of share certificates dated November 15, 2024

pdf

Novartis India Ltd.

14 Nov 2024

886.15

0.37%

Corp. Note

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Filing of Intimation received from Company`s RTA for the loss of share certificate by the shareholder as on November 14, 2024 under reg 39(3) of SEBI LODR

pdf

Novartis India Ltd.

14 Nov 2024

886.15

0.37%

Corp. Note

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Filing the intimation received from Company`s RTA for the issue of Duplicate Share certificate to the Shareholder on account of loss of share certificate as on November 13, 2024

pdf

Novartis India Ltd.

14 Nov 2024

886.15

0.37%

Corp. Note

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Filing of Intimation received from Company RTA in relation to the Loss of Share Certificates by the Shareholder as on November 13, 2024, under Reg 39(3) of SEBI LODR 2015.

pdf

Novartis India Ltd.

05 Nov 2024

886.15

0.37%

Campus hiring soars as GCCs seek freshers skilled in data science and AI

Business Standard

Companies like Wells Fargo, JPMorgan Chase, Novartis, Epsilon, and EQ India are actively hiring from engineering colleges, business schools, and general degree institutions in India

Novartis India Ltd. is trading below all available SMAs

Novartis India Ltd.

28 Oct 2024

886.15

0.37%

Company Update

NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Filing of intimation regarding the publication of financial results for the Quarter and Half year ended September 30, 2024 in newspapers i.e Financial express and Navshakti on October 26, 2024

pdf

Novartis India Ltd.

25 Oct 2024

886.15

0.37%

Result

NOVARTIS INDIA LTD. - 500672 - Filing Of The Outcome Of Board Meeting And Unaudited Financial …

BSE India

Filing of the outcome of Board Meeting and Unaudited Financial Results for the quarter and half year ended September 30, 2024

pdf

Is Novartis India Ltd. worth buying?

70 Votes:

Buy 74.29%

Sell 15.71%

Hold 10.0%